TY - JOUR
T1 - Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis
AU - Williams, Trevor F.
AU - Powers, Albert R.
AU - Ellman, Lauren M.
AU - Corlett, Philip R.
AU - Strauss, Gregory P.
AU - Schiffman, Jason
AU - Waltz, James A.
AU - Silverstein, Steven M.
AU - Woods, Scott W.
AU - Walker, Elaine F.
AU - Gold, James M.
AU - Mittal, Vijay A.
N1 - Funding Information:
The data collection for this project was specifically funded by R01MH112545, R01MH120088, R01MH103231, and R01MH110374. These funds were used to compensate participants, pay study staff, and purchase necessary data collection materials.
Funding Information:
The authors report no conflicts of interest. This research was funded by the National Institutes of Health ( R01MH112545 , R01MH120088 , R01MH103231 , R01MH110374 ).
Publisher Copyright:
© 2022
PY - 2022/6
Y1 - 2022/6
N2 - Self-report questionnaires have been developed to efficiently assess psychosis risk and vulnerability. Despite this, the validity of these questionnaires for assessing specific positive symptoms in those at clinical high risk for psychosis (CHR) is unclear. Positive symptoms have largely been treated as a uniform construct in this critical population and there have been no reports on the construct validity of questionnaires for assessing specific symptoms. The present study examined the convergent, discriminant, and criterion validity of the Launay Slade Hallucination Scale-Revised (LSHS-R), Prodromal Questionnaire-Brief (PQB), and Community Assessment of Psychic Experiences positive scale (CAPE-P) using a multimethod approach. CHR individuals (N = 71) and healthy controls (HC; N = 71) completed structured clinical interviews, self-report questionnaires, and neuropsychological tests. Questionnaire intercorrelations indicated strong convergent validity (i.e., all rs >.50); however, evidence for discriminant validity was more variable. In examining relations to interviewer-assessed psychosis symptoms, all questionnaires demonstrated evidence of criterion validity, though the PQB showed the strongest convergent correlations (e.g., r =.48 with total symptoms). In terms of discriminant validity for specific positive symptoms, results were again more variable. PQB subscales demonstrated limited specificity with positive symptoms, whereas CAPE-P subscales showed some specificity and the LSHS-R showed high specificity. In addition, when correlations with internalizing and externalizing symptoms were examined, only the PQB showed consistent significant correlations. These results are interpreted in terms of the strengths and limitations of each measure, their value for screening, and their potential utility for clarifying differences between specific positive symptoms.
AB - Self-report questionnaires have been developed to efficiently assess psychosis risk and vulnerability. Despite this, the validity of these questionnaires for assessing specific positive symptoms in those at clinical high risk for psychosis (CHR) is unclear. Positive symptoms have largely been treated as a uniform construct in this critical population and there have been no reports on the construct validity of questionnaires for assessing specific symptoms. The present study examined the convergent, discriminant, and criterion validity of the Launay Slade Hallucination Scale-Revised (LSHS-R), Prodromal Questionnaire-Brief (PQB), and Community Assessment of Psychic Experiences positive scale (CAPE-P) using a multimethod approach. CHR individuals (N = 71) and healthy controls (HC; N = 71) completed structured clinical interviews, self-report questionnaires, and neuropsychological tests. Questionnaire intercorrelations indicated strong convergent validity (i.e., all rs >.50); however, evidence for discriminant validity was more variable. In examining relations to interviewer-assessed psychosis symptoms, all questionnaires demonstrated evidence of criterion validity, though the PQB showed the strongest convergent correlations (e.g., r =.48 with total symptoms). In terms of discriminant validity for specific positive symptoms, results were again more variable. PQB subscales demonstrated limited specificity with positive symptoms, whereas CAPE-P subscales showed some specificity and the LSHS-R showed high specificity. In addition, when correlations with internalizing and externalizing symptoms were examined, only the PQB showed consistent significant correlations. These results are interpreted in terms of the strengths and limitations of each measure, their value for screening, and their potential utility for clarifying differences between specific positive symptoms.
KW - Clinical high risk
KW - Construct validity
KW - Positive symptoms
KW - Questionnaires
UR - http://www.scopus.com/inward/record.url?scp=85130544995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130544995&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2022.05.006
DO - 10.1016/j.schres.2022.05.006
M3 - Article
C2 - 35597134
AN - SCOPUS:85130544995
SN - 0920-9964
VL - 244
SP - 58
EP - 65
JO - Schizophrenia Research
JF - Schizophrenia Research
ER -